Lv75
4810 积分 2023-03-06 加入
APL-like subset within NPM1-mutated AML: A distinct immunophenotype correlating with early vascular complications
17天前
已完结
Venetoclax and hypomethylating agents in critically ill patients with newly diagnosed acute myeloid leukaemia
3个月前
已完结
How I diagnose and treat myeloid/lymphoid neoplasms with tyrosine kinase gene fusions
4个月前
已完结
Mapping AML heterogeneity - multi-cohort transcriptomic analysis identifies novel clusters and divergent ex-vivo drug responses
4个月前
已完结
Reduced dose and shorter duration venetoclax regimens are effective for newly diagnosed acute myeloid leukemia patients not considered fit for intensive treatment
4个月前
已完结
Single‐cell transcriptome profiling reveals blast cell heterogeneity and identifies novel therapeutic target IKZF2 in t(8;21) acute myeloid leukaemia
6个月前
已完结
The AML cellular state space unveils NPM1 immune evasion subtypes with distinct clinical outcomes
6个月前
已完结
Dynamic evolution of venetoclax resistance in acute myeloid leukemia unveiled by longitudinal single-cell RNA-seq
6个月前
已完结
Deciphering human macrophage development at single-cell resolution
6个月前
已完结
ZMYM2‐FLT3 Fusion Gene: Implications for Chromosomal Instability and Proliferation in Myeloid/Lymphoid Neoplasms
7个月前
已完结
皖公网安备34019202002308
